Tor Generics

Tor Generics is a privately held pharmaceutical company based in New Jersey that specializes in the development and commercialization of generic prescription drugs for the United States market. The company focuses on Abbreviated New Drug Application (ANDA) submissions, leveraging a lean business model to bring cost-effective medications to patients. Tor Generics manages the entire product lifecycle from formulation development and regulatory filing to supply chain management and distribution. Their portfolio primarily includes small molecule oral solids targeting therapeutic areas such as gastroenterology and neuromuscular disorders. By partnering with global manufacturing organizations, the company ensures a consistent supply of high-quality, affordable pharmaceuticals. Tor Generics aims to address market needs for niche generic products while maintaining rigorous compliance with FDA standards.